Save 20% on Press Releases and More with NNW Prime! Click to View Details
WednesdayMar 15, 2017 11:00 am

Tandy Leather Factory (NASDAQ: TLF) Starts Presentation at 29th Annual Roth Conference

Tandy Leather Factory (NASDAQ: TLF) operates as a retailer and wholesale distributor of a range of leather and related products. The company offers leather, leatherworking tools, buckles and adornments for belts, leather dyes and finishes, and saddle and tack hardware. It also manufactures leather lacing and do-it-yourself kits. It serves individuals, wholesale distributors, tack and saddle shops, western stores, craft stores and craft store chains, other large volume purchasers, manufacturers, retailers, youth groups, summer camps, quine-related shops, cobblers and dealers, as well as institutions, such as prisons and prisoners, schools, and hospitals. For more information, visit the company’s website at…

Continue Reading

WednesdayMar 15, 2017 11:00 am

Synthetic Biologics Inc. (NYSE: SYN) Starts Presentation at 29th Annual Roth Conference

Synthetic Biologics (NYSE: SYN) is a late-stage clinical company that engages in developing therapeutics designed to preserve the microbiome to protect and restore the health of patients in the United States. Its lead product candidates in phase III development include SYN-010, which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation; and SYN-004 (ribaxamase) that is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) beta-lactam antibiotics for the prevention of C. difficile infection (CDI), antibiotic-associated diarrhea (AAD),…

Continue Reading

WednesdayMar 15, 2017 11:00 am

ITM Power Plc (ITMPF) Starts Presentation at 29th Annual ROTH Conference

ITM Power (OTC: ITMPF) designs, manufactures, and sells hydrogen energy systems for energy storage and clean fuel production in the United Kingdom. It offers HGas for power-to-gas applications; HFuel, a self-contained module for refueling hydrogen-powered road vehicles and forklift trucks; and HPac, a proton-exchange membrane electrolyser. The company is also involved in the research and development of scientific and engineering projects; development and manufacture of prototype products; and sale of electrolysis equipment and hydrogen storage solutions. Additionally, the company operates three hydrogen refueling stations. For more information, visit the company’s website at www.itm-power.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation…

Continue Reading

WednesdayMar 15, 2017 11:00 am

Professional Diversity Net, Inc. (NASDAQ: IPDN) Starts Presentation at 29th Annual Roth Conference

Professional Diversity Net (NASDAQ: IPDN) operates online professional networking communities with career resources in the United States. It operates through three segments, Professional Diversity Network, National Association of Professional Women and Noble Voice Operations. The company serves various cultural groups such as Hispanic-Americans, African-Americans, Asian-Americans, the disabled, military professionals, LBGT communities, plus women’s groups, students and graduates. It offers single and multiple job postings, recruitment media, talent recruitment communities, corporate memberships, hiring campaign marketing and advertising as well as e-newsletter marketing, research and outreach services. For more information, visit the company’s website at www.profusional.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news…

Continue Reading

WednesdayMar 15, 2017 10:30 am

Mateon Therapeutics, Inc. (NASDAQ: MATN) Starts Presentation at 29th Annual Roth Conference

Mateon Therapeutics (NASDAQ: MATN) is a biopharmaceutical company that focuses on the development of vascular disrupting agents for the treatment of cancer in the United States. Its principal clinical stage product includes fosbretabulin tromethamine, a reversible tubulin binding agent, which has completed Phase II clinical trial for treating recurrent ovarian cancer; and in Phase II clinical trial for treating gastrointestinal neuroendocrine tumors. The company also develops OXi4503 that is in Phase I/II clinical trial stage for treating patients with relapsed or refractory acute myelogenous leukemia or myelodysplastic syndromes. For more information, visit the company’s website at www.mateon.com. About NetworkNewsWire NetworkNewsWire…

Continue Reading

WednesdayMar 15, 2017 10:30 am

KemPharm, Inc. (NASDAQ: KMPH) Starts Presentation at 29th Annual Roth Conference

KemPharm (NASDAQ: KMPH) is a clinical-stage specialty pharmaceutical company that discovers and develops new proprietary prodrugs in the United States. Its advanced product candidate is KP201/APAP, which consists of KP201 prodrug of hydrocodone formulated in combination with acetaminophen (APAP). The company is also developing KP201/APAP as an immediate release (IR) product candidate for the treatment of acute pain, as well as engages in designing KP201/APAP with abuse-deterrent properties to address the epidemic of opioid abuse. The company is also involved in developing KP201/IR (APAP-free), an IR formulation of KP201 without APAP for the short-term management of acute pain. For more…

Continue Reading

WednesdayMar 15, 2017 10:30 am

Cutera, Inc. (NASDAQ: CUTR) Starts Presentation at 29th Annual ROTH Conference

Cutera (NASDAQ: CUTR) is a medical device company that designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems for practitioners worldwide. Since 1998, the Brisbane, California-based company has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue…

Continue Reading

WednesdayMar 15, 2017 10:30 am

Global Self Storage, Inc. (NASDAQ: SELF) Starts Presentation at 29th Annual ROTH Conference

Global Self Storage (NASDAQ: SELF) is a self-administered and self-managed real estate investment trust (“REIT”) focused on the ownership, operation, acquisition, development and redevelopment of self-storage facilities in the United States. The company’s self-storage facilities are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. Global currently owns and operates, through its wholly owned subsidiaries, seven self-storage properties located in New York, Pennsylvania, Illinois, Indiana, and South Carolina. For more information, visit the company’s website at www.globalselfstorage.us. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array…

Continue Reading

WednesdayMar 15, 2017 10:30 am

Cemtrex, Inc. (NASDAQ: CETX) Starts Presentation at 29th Annual ROTH Conference

Cemtrex (NASDAQ: CETX) is a diversified industrial and manufacturing company that provides a wide array of solutions to meet today’s technology challenges. Cemtrex provides manufacturing services of advanced custom engineered electronics, industrial services, monitoring instruments for industrial processes and environmental compliance, and systems for controlling particulates, hazardous gases, emissions of Greenhouse gases, and other regulated pollutants used in emissions trading globally. For more information, visit the company’s website at www.cemtrex.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an…

Continue Reading

WednesdayMar 15, 2017 10:00 am

Mesoblast Ltd. (NASDAQ: MESO) Starts Presentation at 29th Annual Roth Conference

Mesoblast (NASDAQ: MESO) develops cell-based medicines. The company has leveraged its proprietary technology platform based on specialized cells, known as mesenchymal lineage adult stem cells, to establish a portfolio of late-stage product candidates. Its allogeneic off-the-shelf cell product candidates target advanced stages of diseases with high, unmet medical needs including cardiovascular diseases, immune-mediated and inflammatory conditions, orthopaedic disorders, and oncologic/hematologic conditions. Mesoblast’s lead product candidates include MPC-150-IM, a phase 3 product candidate under investigation for the treatment of chronic congestive heart failure; and MPC-06-ID, a phase 3 product candidate under investigation for the treatment of chronic low back pain due…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000